Few & Far Between
By Chris O'Brien
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Chris O'Brien
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 35
Description
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for conversations on the cutting edge - from clinical research and policymakers to rare disease advocates and industry leaders.
| Episode | Date |
|---|---|
|
Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal
|
Apr 25, 2024 |
|
Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center
|
Mar 26, 2024 |
|
Episode 38: Dr. Ole Isacson, Professor of Neurology and Neuroscience, Harvard Medical School
|
Feb 22, 2024 |
|
Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche
|
Jan 24, 2024 |
|
Episode 36: Zak Kohane, Department of Biomedical Informatics at Harvard Medical School
|
Dec 05, 2023 |
|
Episode 35: Charlene Son Rigby, CEO at Global Genes
|
Nov 14, 2023 |
|
Episode 34: Dan Mandell, CEO at GRO Biosciences
|
Oct 10, 2023 |
|
Episode 33: Diana Sims-Silbermann, Clinician and Former Senior Trial Manager at Janssen Pharmaceuticals
|
Sep 20, 2023 |
|
Episode 32: Stephanie Wisner, Author, Co-Founder at Centivax
|
Aug 17, 2023 |
|
Episode 31: Pam Cusick, SVP, Rare Patient Voice
|
Jun 20, 2023 |
|
Episode 30, Part Two: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH
|
May 23, 2023 |
|
Episode 30, Part One: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH
|
May 03, 2023 |
|
Episode 29: Mika Newton, CEO at XCures
|
Mar 21, 2023 |
|
Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio
|
Feb 23, 2023 |
|
Episode 27, Part 2: Jamie Heywood, Biotech Engineer and Entrepreneur
|
Jan 31, 2023 |
|
Episode 27, Part 1: Jamie Heywood, Biotech Engineer and Entrepreneur
|
Jan 12, 2023 |
|
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
|
Dec 07, 2022 |
|
Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
|
Nov 17, 2022 |
|
Episode 24: Gadi Lachman, President and CEO, TriNetX
|
Oct 06, 2022 |
|
Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India
|
Sep 14, 2022 |
|
Episode 22: Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics, Host of Lady Scientist Podcast
|
Jul 26, 2022 |
|
Episode 21: Jill Hawkins, Founder and President of the FAM177A1 Research Fund
|
Jun 23, 2022 |
|
Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.
|
May 18, 2022 |
|
Episode 19: Leslie Michelson, Founder and CEO, Private Health Management
|
Apr 20, 2022 |
|
Episode 18: Karen Petrou and David Brint - BioBonds
|
Mar 23, 2022 |
|
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
|
Jan 12, 2022 |
|
Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi
|
Dec 15, 2021 |
|
Episode 15: Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain
|
Dec 01, 2021 |
|
Episode 14: Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases, and Trish Flanagan, President at the Yellow Brick Road Project
|
Nov 10, 2021 |
|
Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime
|
Oct 27, 2021 |
|
Episode 12: Effie Parks and Spela Mirosevic
|
Oct 13, 2021 |
|
Episode 11: Rebecca Stewart and Nicola Miller from Rare Revolution Magazine
|
Sep 28, 2021 |
|
Episode 10: Sharon Terry, CEO Genetic Alliance
|
Sep 15, 2021 |
|
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
|
Sep 01, 2021 |
|
Episode 8: David Rose, Rare Disease Speaker and Advocate
|
Aug 18, 2021 |